Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study
Fumihiko Urabe(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Hiroki Yamada(Keio University), Masaki Hashimoto(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Wataru Fukuokaya(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Masaya Murakami(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Shuhei Hara(Jikei University School of Medicine), Shunsuke Tsuzuki(Jikei University School of Medicine), Yu Imai(Jikei University School of Medicine), Mahito Atsuta(Jikei University Kashiwa hospital), Hidetsugu Takahashi(Jikei University School of Medicine), Brendan A. Yanada(Jikei University School of Medicine), Hirokazu Kagawa(Jikei University School of Medicine), Kenichi Hata(Jikei University School of Medicine), Toshihiro Yamamoto(Jikei University School of Medicine), Taro Igarashi(Jikei University School of Medicine)
Cited by 6
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112
Extracellular vesicles in the development of organ‐specific metastasis
|Journal of Extracellular Vesicles|2021|101